LDLR and familial hypercholesterolemia: Here, our results indicated that adding this hypercholesterolemia-associated lysophospholipid marker could have direct effects on increasing plasma and liver cholesterol levels in both LDLR−/− and WT mice, suggesting an important cholesterol-raising role of LPA 16:0.